PepT1 oligopeptide transporter (SLC15A1) gene polymorphism in inflammatory bowel disease

Marco Zucchelli, Leif Torkvist, Francesca Bresso, Jonas Halfvarson, Anna Hellquist, Francesca Anedda, Ghazaleh Assadi, Gunnar B. Lindgren, Monika Svanfeldt, Martin Janson, Colin L. Noble, Sven Pettersson, Maarit Lappalainen, Paulina Paavola-Sakki, Leena Halme, Martti Färkkilä, Ulla Turunen, Jack Satsangi, Kimmo Kontula, Robert LöfbergJuha Kere, Mauro D'Amato

Research output: Contribution to journalArticleResearchpeer-review

49 Citations (Scopus)


Background: Human polymorphisms affecting gut epithelial barrier and interactions with bacteria predispose to the inflammatory bowel diseases (IBD) Crohn's disease (CD) and ulcerative colitis (UC). The intestinal transporter PepT1, encoded by the SLC15A1 gene, mediates intracellular uptake of bacterial products that can induce inflammation and NF-κB activation upon binding to NOD2, a protein often mutated in CD. Hence, we tested SLC15A1 polymorphisms for association with IBD. Methods: Twelve SLC15A1 single nucleotide polymorphisms (SNPs) were genotyped in 1783 individuals from 2 cohorts of Swedish and Finnish IBD patients and controls. An in vitro system was set up to evaluate the potential impact of SLC15A1 polymorphism on PepT1 transporter function by quantification of NOD2-mediated activation of NF-κB. Results: The common allele (C) of a coding polymorphism (rs2297322, Ser117Asn) was associated with CD susceptibility both in Sweden and in Finland, but with genetic effects in opposite directions (risk and protection, respectively). The best evidence of association was found in both populations when the analysis was performed on individuals not carrying NOD2 common risk alleles (Sweden allelic P = 0.0007, OR 1.97, 95% confidence interval [CI] 1.34-2.92; Finland genotype P = 0.0013, OR 0.63, 95% CI 0.44-0.90). The PepT1 variant encoded by the C allele (PepT1-Ser117) was associated with reduced signaling downstream of NOD2 (P < 0.0001 compared to Pept1-Asn117). Conclusions: A functional polymorphism in the SLC15A1 gene might be of relevance to inflammation and antibacterial responses in IBD. Whether this polymorphism truly contributes to disease susceptibility needs to be further addressed, and should stimulate additional studies in other populations.

Original languageEnglish
Pages (from-to)1562-1569
Number of pages8
JournalInflammatory Bowel Diseases
Issue number10
Publication statusPublished - 26 Nov 2009
Externally publishedYes


  • Bacteria
  • Inflammation
  • Inflammatory bowel disease
  • NOD2
  • PepT1

Cite this